You are here: Industry Insights > Multiple

News List

Regular Vaccines Advised With Multiple Sclerosis drugs
August 29, 2019
If you have multiple sclerosis (MS), you can and should receive recommended vaccinations -- including annual flu shots, a new American Academy of Neurology guideline says.
Guidelines Updated for Vaccination in Multiple Sclerosis drugs
August 29, 2019
Guidelines have been updated on vaccinations in patients with multiple sclerosis (MS); a practice guideline update summary was published online in Neurology.
Novel Therapy Treats Triple-Class Refractory Multiple Myeloma drugs
August 26, 2019
The combination of selinexor and dexamethasone seems effective in treating patients with multiple myeloma that has not responded to standard therapies...
Patient Preferences Explored in Multiple Myeloma Treatment drugs
August 21, 2019
An Eastern Cooperative Oncology Group (ECOG) performance status of ≥2 is linked to lower treatment satisfaction in patients with relapsed or refractory multiple myeloma (RRMM)...
SAVED Score Can Predict Risk for VTE in Multiple Myeloma drugs
August 19, 2019
For patients with multiple myeloma (MM) receiving immunomodulatory drugs (IMiDs), a risk assessment model, SAVED, can predict the risk for venous thromboembolism (VTE)...
Cost Burden of Disease Progression High in Multiple Myeloma drugs
August 16, 2019
The economic burden of disease progression is considerable among multiple myeloma (MM) patients receiving drug therapy across all lines of therapy (LOTs)...
New Score Predicts Risk for VTE in Those With Multiple Myeloma drugs
August 08, 2019
A new risk prediction score outperforms current guidelines for predicting venous thromboembolism (VTE) in multiple myeloma (MM), according to a study published online in the American Journal of Hematology
Vaccination Does Not Up Risk for Developing Multiple Sclerosis drugs
August 07, 2019
Evidence shows that vaccination is not associated with an increased risk for being diagnosed with multiple sclerosis (MS) within the next five years, according to a study published online July 30 in Neurology.
MGUS Can Progress to Multiple Myeloma Within Five Years drugs
July 24, 2019
Individuals with low- or intermediate-risk monoclonal gammopathy of undetermined significance (MGUS) can experience progression...
FRAX Score Underestimates Risk for Fracture in Multiple Sclerosis drugs
July 22, 2019
FRAX Score Underestimates Risk for Fracture in Multiple Sclerosis.

Previous page 1 2 3 Next page